BIOFILCHEM — Biofil Chemicals and Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Market Cap
IN₹987.98m
Enterprise Value
IN₹969.54m
Revenue
IN₹400.35m

Annual balance sheet for Biofil Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2.56	4.41	1.45	0.377	22.8
Net Total Accounts Receivable
Net Total Receivables	297	172	71.7	205	330
Total Inventory
Total Other Current Assets
Total Current Assets	323	235	93.1	224	384
Net Property, Plant And Equipment	101	97.8	94.2	90	86.2
Other Long Term Assets
Total Assets	424	332	187	314	471
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	275	168	14.9	137	285
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	275	171	18.9	141	289
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	149	161	168	173	182
Total Liabilities & Shareholders' Equity	424	332	187	314	471
Total Common Shares Outstanding